NCT00562419 2010-10-27CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With IrinotecanAdnexus, A Bristol-Myers Squibb R&D CompanyPhase 2 Unknown72 enrolled